Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Condition:   Chronic Obstructive Pulmonary Disease (COPD) Interventions:   Drug: Placebo;   Drug: Tozorakimab Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials